Eosinophilic Granulomatosis With Polyangiitis Clinical Trials

26 clinical trials for Eosinophilic Granulomatosis With Polyangiitis across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases — RECRUITING · PHASE3
• A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Investigate the Efficacy and Safety of NS-229 in the Treatment of Eosinophilic Granulomatosis With Polyangiitis — RECRUITING · PHASE2
• Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis — RECRUITING
• Vasculitis Pregnancy Registry — RECRUITING
• One-Time DNA Study for Vasculitis — RECRUITING
• VCRC Tissue Repository — RECRUITING
• Clinical Transcriptomics in Systemic Vasculitis (CUTIS) — RECRUITING
• A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis （EGPA） — RECRUITING · PHASE2
• Characterization of Eosinophil Subtypes and Disease-Specific Biomarkers in Eosinophilic Myocarditis (The EMBASSY Study) — NOT_YET_RECRUITING
• Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA) — ACTIVE_NOT_RECRUITING · PHASE3
• A Randomised, Double-blind, Active-controlled 52-week Study with an Open-label Extension to Evaluate the Efficacy and Safety of Benralizumab Compared to Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA) in Patients Receiving Standard of Care Therapy (MANDARA Study). — TERMINATED · PHASE3
• Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis — ACTIVE_NOT_RECRUITING · PHASE2
• Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment — NOT_YET_RECRUITING · PHASE3
• NUCALA® Special Drug Use Investigation (EGPA, Long-term) — COMPLETED
• Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis — COMPLETED · PHASE2
• Rituximab in Eosinophilic Granulomatosis With Polyangiitis — COMPLETED · PHASE3
• Maintenance of Remission With Rituximab Versus Azathioprine for Newly-diagnosed or Relapsing Eosinophilic Granulomatosis With Polyangiitis. — COMPLETED · PHASE3
• Study of Mepolizumab-based Regimen Compared to Conventional Therapeutic Strategy in Patients With Eosinophilic Granulomatosis With Polyangiitis (E-merge) — ACTIVE_NOT_RECRUITING · PHASE3
• A RAndomised Placebo Controlled Trial - to Explore the Efficacy and Mechanism of Action of Tezepelumab in EGPA- RACE-MATE — OTHER · PHASE2
• Eosinophil Subpopulations in Eosinophilic-associated Diseases — NOT_YET_RECRUITING
• Mepolizumab Long-term Study to Assess Real World Safety and Effectiveness of Eosinophilic Granulomatosis With Polyangiitis (EGPA) in Japan — COMPLETED
• Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921 — COMPLETED · PHASE3
• The Epigenomic Signature of Eosinophilic Granulomatosis With Polyangiitis — OTHER
• eGPA and local inflammation within the ENT area; Impact of Mepolizumab treatment on the nasal microbiome and local and systemic immune response in eosinophilic granulomatosis with polyangitis (eGPA) — TERMINATED · PHASE4
• Pediatric Vasculitis Initiative — OTHER
• PRagmatic Analysis of Vitamin D in ANCA-Associated Vasculitis — COMPLETED · NA

Refine this search